These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 25523732

  • 1. Treatment updates regarding anaplastic oligodendroglioma and anaplastic oligoastrocytoma.
    Khan KA, Abbasi AN, Ali N.
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):935-9. PubMed ID: 25523732
    [Abstract] [Full Text] [Related]

  • 2. 1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.
    Jiang H, Ren X, Cui X, Wang J, Jia W, Zhou Z, Lin S.
    Neuro Oncol; 2013 Jun; 15(6):775-82. PubMed ID: 23486687
    [Abstract] [Full Text] [Related]

  • 3. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG, Jiang H, Lim-Fat MJ, Sahebjam S, Kiehl TR, Karamchandani J, Coire C, Chung C, Millar BA, Laperriere N, Mason WP.
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [Abstract] [Full Text] [Related]

  • 4. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
    Speirs CK, Simpson JR, Robinson CG, DeWees TA, Tran DD, Linette G, Chicoine MR, Dacey RG, Rich KM, Dowling JL, Leuthardt EC, Zipfel GJ, Kim AH, Huang J.
    Int J Radiat Oncol Biol Phys; 2015 Feb 01; 91(2):268-76. PubMed ID: 25636755
    [Abstract] [Full Text] [Related]

  • 5. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.
    Kouwenhoven MC, Gorlia T, Kros JM, Ibdaih A, Brandes AA, Bromberg JE, Mokhtari K, van Duinen SG, Teepen JL, Wesseling P, Vandenbos F, Grisold W, Sipos L, Mirimanoff R, Vecht CJ, Allgeier A, Lacombe D, van den Bent MJ.
    Neuro Oncol; 2009 Dec 01; 11(6):737-46. PubMed ID: 19224764
    [Abstract] [Full Text] [Related]

  • 6. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.
    Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y.
    J Neurooncol; 2019 Jan 01; 141(1):205-211. PubMed ID: 30565028
    [Abstract] [Full Text] [Related]

  • 7. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
    Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Curran W, Mehta M.
    J Clin Oncol; 2013 Jan 20; 31(3):337-43. PubMed ID: 23071247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A, German Glioma Network.
    Clin Cancer Res; 2007 Dec 01; 13(23):6933-7. PubMed ID: 18056167
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted).
    Anderson MD, Gilbert MR.
    J Natl Compr Canc Netw; 2014 May 01; 12(5):665-72. PubMed ID: 24812135
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    van den Bent MJ, Smits M, Kros JM, Chang SM.
    J Clin Oncol; 2017 Jul 20; 35(21):2394-2401. PubMed ID: 28640702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.